Rhythm Pharmaceuticals, Inc.
RYTM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$260,602 | -$184,678 | -$181,119 | -$69,612 |
| Dep. & Amort. | $1,563 | $1,758 | $1,672 | $1,158 |
| Deferred Tax | $0 | $0 | $0 | -$100,000 |
| Stock-Based Comp. | $39,682 | $32,553 | $19,831 | $20,804 |
| Change in WC | $10,575 | $4,807 | -$19,724 | $1,897 |
| Other Non-Cash | $94,903 | $9,403 | $5,912 | -$250 |
| Operating Cash Flow | -$113,879 | -$136,157 | -$173,428 | -$146,003 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$47 | -$4,281 | -$5,434 |
| Net Acquisitions | $0 | $0 | $4,000 | $100,000 |
| Inv. Purchases | -$268,313 | -$354,918 | -$251,937 | -$524,972 |
| Inv. Sales/Matur. | $260,640 | $354,967 | $284,247 | $361,247 |
| Other Inv. Act. | -$40,500 | -$5,667 | -$4,000 | $7,000 |
| Investing Cash Flow | -$48,173 | -$5,665 | $28,029 | -$62,159 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$12,900 | $0 | $0 | $0 |
| Stock Issued | $195,242 | $48,875 | $131,112 | $161,726 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$3,970 | $0 | $0 | $0 |
| Other Fin. Act. | $12,870 | $25,493 | $82,716 | $4,755 |
| Financing Cash Flow | $191,242 | $74,368 | $213,828 | $166,481 |
| Forex Effect | $2 | -$142 | $0 | $0 |
| Net Chg. in Cash | $29,192 | -$67,596 | $68,429 | -$41,681 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $60,409 | $128,005 | $59,576 | $101,257 |
| End Cash | $89,601 | $60,409 | $128,005 | $59,576 |
| Free Cash Flow | -$113,879 | -$136,204 | -$177,709 | -$151,437 |